What they were paid
Denali Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $60,000 | $84,095 | $157,285 | $0 | $301,380 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Denali Therapeutics Inc. DEF 14A filed April 21, 2026, accession 0001714899-26-000054, and prior-year filings. Open the filing on EDGAR.
Committees
FY2025 · as the proxy prints themNominating/Governance
The rest of the Denali Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| David Schenkein, M.D | Independent Director | $311,380 |
| Jay Flatley | Independent Director | $316,380 |
| Julian C. Baker | Chair of the Board | $474,348 |
| Nancy A. Thornberry | Independent Director | $306,380 |
| Peter Klein | Independent Director | $318,880 |
| Ryan J. Watts, Ph.D | Director | $0 |
| Steve E. Krognes | Independent Director | $297,149 |
| Tim Van Hauwermeiren | Independent Director | $467,961 |
The full Denali Therapeutics compensation record
free company briefThis page is one director within Denali Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat